HLS Therapeutics Inc (TSE:HLS)

HLS Therapeutics Inc (HLS) Stock Price & Analysis


HLS Stock Chart & Stats

Day’s RangeC$0 - C$0
52-Week RangeC$4.12 - C$13.89
Previous CloseC$4.26
Average Volume (3M)31.49K
Market Cap
Enterprise ValueC$238.20M
Total Cash (Recent Filing)$21.21M
Total Debt (Recent Filing)$95.20M
Price to Earnings (P/E)-4.1
Aug 10, 2023
0.15 (3.51%)
Share Statistics
EPS (TTM)-1.05
Shares Outstanding32,523,233
10 Day Avg. Volume45,417
30 Day Avg. Volume31,493
Standard Deviation0.15
Financial Highlights & Ratios
Price to Book (P/B)-2.05
Price to Sales (P/S)9.43
Price to Cash Flow (P/CF)8.70
P/FCF Ratio5.90
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.94
Enterprise Value/Gross Profit4.22
Enterprise Value/Ebitda30.86
Price Target Upside252.11% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5

HLS Therapeutics Inc News




What was HLS Therapeutics Inc’s price range in the past 12 months?
HLS Therapeutics Inc lowest stock price was C$4.12 and its highest was C$13.89 in the past 12 months.
    What is HLS Therapeutics Inc’s market cap?
    Currently, no data Available
    When is HLS Therapeutics Inc’s upcoming earnings report date?
    HLS Therapeutics Inc’s upcoming earnings report date is Aug 10, 2023 which is in 64 days.
      How were HLS Therapeutics Inc’s earnings last quarter?
      HLS Therapeutics Inc released its earnings results on May 11, 2023. The company reported -C$0.242 earnings per share for the quarter, missing the consensus estimate of -C$0.159 by -C$0.083.
        Is HLS Therapeutics Inc overvalued?
        According to Wall Street analysts HLS Therapeutics Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does HLS Therapeutics Inc pay dividends?
          HLS Therapeutics Inc pays a Quarterly dividend of C$0.05 which represents an annual dividend yield of 4.65%. See more information on HLS Therapeutics Inc dividends here
            What is HLS Therapeutics Inc’s EPS estimate?
            HLS Therapeutics Inc’s EPS estimate is -C$0.17.
              How many shares outstanding does HLS Therapeutics Inc have?
              HLS Therapeutics Inc has 32,350,525 shares outstanding.
                What happened to HLS Therapeutics Inc’s price movement after its last earnings report?
                HLS Therapeutics Inc reported an EPS of -C$0.242 in its last earnings report, missing expectations of -C$0.159. Following the earnings report the stock price went down -10.87%.
                  Which hedge fund is a major shareholder of HLS Therapeutics Inc?
                  Currently, no hedge funds are holding shares in TSE:HLS


                  HLS Therapeutics Inc Stock Smart Score

                  The HLS Therapeutics Inc stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  HLS Therapeutics Inc

                  HLS Therapeutics Inc is a specialty pharmaceutical company. It is focused on the acquisition and commercialization of branded pharmaceutical products in the North American markets. The company is focused on treatment products for the central nervous system (CNS), and cardiovascular specialties. The company products include Clozaril, Absorica, Vascepa, CSAN Pronto, Trinomia and Perseris. The company earns revenue in the form of product sales and royalties, out of which product sales contribute to the majority of the revenue. The company operates in Canada and the United States.


                  Top 5 ETFs holding HLS

                  Currently, no data available
                  Please return soon. This page is being updated.
                  Up to five ETFs with an Outperform Smart Score that hold HLS. The ETFs are listed according to market value of HLS within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Helix BioPharma
                  DRI Healthcare

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis